Cyberattack to Hit Boston Scientific's 2026 Sales
The company's profit is also expected to take a hit due to the cyberattack, according to recent announcements
Story timeline2 updates
Boston Scientific no longer expects to meet its previously issued third-quarter and full-year 2026 sales and adjusted profit forecasts.
Story published. The company's profit is also expected to take a hit due to the cyberattack, according to recent announcements
Boston Scientific has announced that it has experienced a cyberattack, which is likely to have significant financial implications for the company.
The cyberattack is expected to negatively impact Boston Scientific's sales in 2026. This forecast suggests that the company is bracing for a challenging year ahead.
In addition to the expected decline in sales, the cyberattack is also likely to hurt Boston Scientific's profit in 2026. This double blow could have far-reaching consequences for the company's financial performance.
Why it matters
The potential decline in sales and profit due to the cyberattack is a significant concern for Boston Scientific. As a major player in the medical technology industry, the company's financial health has a direct impact on its ability to invest in research and development, as well as its competitiveness in the market. The cyberattack's effects on the company's 2026 performance will be closely watched by investors and industry analysts.
